Abstract:Introduction:Comprehensive staging laparotomy and cytoreductive surgery followed by chemotherapy has been the standard of care in advanced ovarian cancer. Neoadjuvant chemotherapy is an alternative in inoperable advanced cases. To select patients amenable for successful cytoreduction, major determinants including CT imaging and laparoscopy could be of value. There is no general accepted model for selection and reproducibility of techniques are a major challenge due to different clinical practice and complexity… Show more
“…A 2018 prospective analysis showed a score of less than 8 to have an 85% predictive value for R0 debulking 24 . Even without a formal scoring system, laparoscopic evaluation can be used to confirm histologic subtype and better assess the amount of unresectable disease when CT imaging results are inconclusive 25 …”
The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of ovarian neoplasms specifically related to the management of peritoneal surface malignancy. These guidelines are developed with input from leading experts, including surgical oncologists, medical oncologists, gynecologic oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence. Cancer 2020;126:2553-2560.
Communication 2554Cancer June 1, 2020 seeding and upstaging of a potentially early-stage cancer. The most common histologic diagnosis is high-grade serous cancer (66% of EOCs), with mucinous cancer, endometrioid cancer, and carcinosarcoma each accounting for about 10%. Clear cell carcinoma and low-grade serous carcinomas are less frequent, accounting for less than 5% of the remaining cancers, and have a strong association with endometriosis and borderline tumors, respectively. Pathological diagnosis should be verified by an experienced gynecologic pathologist and confirmed by immunohistochemical markers that can help to distinguish ovarian cancer from cancers metastatic to the ovary (eg, CK7, CK20, CA125, CEA, WT1, PAX8, p53, estrogen receptor/progesterone receptor). Accurate identification of low-grade serous carcinomas is See companion articles on pages
“…A 2018 prospective analysis showed a score of less than 8 to have an 85% predictive value for R0 debulking 24 . Even without a formal scoring system, laparoscopic evaluation can be used to confirm histologic subtype and better assess the amount of unresectable disease when CT imaging results are inconclusive 25 …”
The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of ovarian neoplasms specifically related to the management of peritoneal surface malignancy. These guidelines are developed with input from leading experts, including surgical oncologists, medical oncologists, gynecologic oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness in the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence. Cancer 2020;126:2553-2560.
Communication 2554Cancer June 1, 2020 seeding and upstaging of a potentially early-stage cancer. The most common histologic diagnosis is high-grade serous cancer (66% of EOCs), with mucinous cancer, endometrioid cancer, and carcinosarcoma each accounting for about 10%. Clear cell carcinoma and low-grade serous carcinomas are less frequent, accounting for less than 5% of the remaining cancers, and have a strong association with endometriosis and borderline tumors, respectively. Pathological diagnosis should be verified by an experienced gynecologic pathologist and confirmed by immunohistochemical markers that can help to distinguish ovarian cancer from cancers metastatic to the ovary (eg, CK7, CK20, CA125, CEA, WT1, PAX8, p53, estrogen receptor/progesterone receptor). Accurate identification of low-grade serous carcinomas is See companion articles on pages
“…Another study evaluated the importance of PCI-CT in the selection of patients for cytoreductive surgery, whereby patients with a score >15 were recommended neoadjuvant chemotherapy. In this study, the authors concluded that PCI-CT and laparoscopy represent the best option to predict the operability in patients with advanced ovarian cancer 41. More recently, Ahmed et al showed high accuracy of CT imaging, with routine use of a standardized PCI form, for a better comprehensive multiregional analysis.…”
Appropriate and accurate pre-operative imaging in epithelial ovarian cancer patients may allow selection of patients that may mostly benefit either from primary cytoreductive surgery or from neoadjuvant chemotherapy. If the patient is considered suitable for upfront surgery, pre-operative imaging may help in planning the surgical approach, to forecast the operating time, and to estimate the need for other consulting specialists. Currently, computed tomography (CT) imaging is the standard of care for pre-operative evaluation of ovarian cancer patients; however, advanced magnetic resonance imaging (MRI) is emerging as a technique that may overcome the limitations of CT imaging, especially for small peritoneal deposits in difficult-to-resect sites. Positron emission tomography (PET)-CT imaging in the pre-operative setting is currently limited, whereas the use of the new hybrid technique PET-MRI is still under evaluation. Since criteria that may preclude optimal cytoreductive surgery may vary, depending on the aggressiveness of the surgical procedure and surgeon skill, multidisciplinary consensus conferences are the ideal platform to evaluate extent of the disease and surgical strategy.
“…MDCT-PCI has a good correlation with surgical-PCI in OC (11,28,(37)(38)(39)(40)(41)(42)(43)(44)(45)(46)(47)(48). In a prospective study including 85 patients with OC, MDCT and laparoscopy correctly diagnosed PMs in 88.2% and 90.6% of patients, respectively.…”
Multidetector computed tomography (MDCT) of the abdomen is currently the imaging examination of choice for the staging and follow-up of ovarian carcinoma (OC). Peritoneal metastases (PMs) represent the most common pathway for the metastatic spread of OC. MDCT scanners, due to several advantages—including increased volume coverage, reduced scanning time, acquisition of thin slices and creation of multiplanar reformations, and three-dimensional reconstructions—provide useful information regarding the early and accurate detection of PMs. Detailed mapping of peritoneal carcinomatosis is feasible, with improved detection of sub-centimeter peritoneal implants and thorough evaluation of curved peritoneal surfaces.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.